Projects funded by the NCN
Photoimmunotherapy targeting HER2 using affibody-based vectors
2015/19/N/NZ7/01336
Keywords:
photoimmunotherapy HER2 affibody
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Lekarski
woj. dolnośląskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 2
Call: PRELUDIUM 10 - announced on 2015-09-15
Amount awarded: 145 200 PLN
Project start date (Y-m-d): 2016-09-05
Project end date (Y-m-d): 2020-09-04
Project duration:: 48 months (the same as in the proposal)
Project status: Project settled
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
- Publication in academic press/journals (1)
- Immunomodulatory activity of IR700-labelled affibody targeting HER2Authors:Justyna Mączyńska, Chiara Da Pieve, Thomas A. Burley Burley, Florian Raes, Anant Shah, Jolanta Saczko, Kevin Harrington, Gabriela Kramer-MarekAcademic press:Cell Death & Disease (rok: 2020, tom: 11, strony: 886), Wydawca: Springer NatureStatus:PublishedDOI:10.1038/s41419-020-03077-6 - link to the publication